CD117 C KIT, 6 ML, EP10 CLONE, SKIN (MAST CELLS), GASTROINTESTINAL STROMAL TUMOR OR SEMINOMA CONTROL by Biocare Medical
OEM#: PME296AACD117 C KIT, 6 ML, EP10 CLONE, SKIN (MAST CELLS), GASTROINTESTINAL STROMAL TUMOR OR SEMINOMA CONTROL by Biocare Medical
CD117/c-kit is a member of Tyrosine Kinase kDa (-3) Receptor (TKR) family and is highly homologous to receptor PDGF and CSF-1. This antibody recognizes the extracellular domain and is expressed by a variety of normal and abnormal cell types. In abnormal cells, CD117 has been shown to label testicular germ cells, endometrial carcinomas, papillary and follicular thyroid carcinomas, small cell carcinomas, melanomas and ovarian epithelial carcinomas. It has also been shown to be an effective marker for mast cell disorders, gastrointestinal stromal tumors and immunotyping of blasts in human bone marrow.CD117/c-kit labels testicular germ cells, melanomas and endometrial, thyroid, small cell and ovarian epithelial carcinomas. It is an effective marker for mast cell disorders, gastrointestinal stromal tumors and human bone marrow blasts.
CD117/c-kit is a member of Tyrosine Kinase kDa (-3) Receptor (TKR) family and is highly homologous to receptor PDGF and CSF-1. This antibody recognizes the extracellular domain and is expressed by a variety of normal and abnormal cell types. In abnormal cells, CD117 has been shown to label testicular germ cells, endometrial carcinomas, papillary and follicular thyroid carcinomas, small cell carcinomas, melanomas and ovarian epithelial carcinomas. It has also been shown to be an effective marker for mast cell disorders, gastrointestinal stromal tumors and immunotyping of blasts in human bone marrow.CD117/c-kit labels testicular germ cells, melanomas and endometrial, thyroid, small cell and ovarian epithelial carcinomas. It is an effective marker for mast cell disorders, gastrointestinal stromal tumors and human bone marrow blasts.
CD117/c-kit is a member of Tyrosine Kinase kDa (-3) Receptor (TKR) family and is highly homologous to receptor PDGF and CSF-1. This antibody recognizes the extracellular domain and is expressed by a variety of normal and abnormal cell types. In abnormal cells, CD117 has been shown to label testicular germ cells, endometrial carcinomas, papillary and follicular thyroid carcinomas, small cell carcinomas, melanomas and ovarian epithelial carcinomas. It has also been shown to be an effective marker for mast cell disorders, gastrointestinal stromal tumors and immunotyping of blasts in human bone marrow.CD117/c-kit labels testicular germ cells, melanomas and endometrial, thyroid, small cell and ovarian epithelial carcinomas. It is an effective marker for mast cell disorders, gastrointestinal stromal tumors and human bone marrow blasts.
CD117/c-kit is a member of Tyrosine Kinase kDa (-3) Receptor (TKR) family and is highly homologous to receptor PDGF and CSF-1. This antibody recognizes the extracellular domain and is expressed by a variety of normal and abnormal cell types. In abnormal cells, CD117 has been shown to label testicular germ cells, endometrial carcinomas, papillary and follicular thyroid carcinomas, small cell carcinomas, melanomas and ovarian epithelial carcinomas. It has also been shown to be an effective marker for mast cell disorders, gastrointestinal stromal tumors and immunotyping of blasts in human bone marrow.CD117/c-kit labels testicular germ cells, melanomas and endometrial, thyroid, small cell and ovarian epithelial carcinomas. It is an effective marker for mast cell disorders, gastrointestinal stromal tumors and human bone marrow blasts.
CD117/c-kit is a member of Tyrosine Kinase kDa (-3) Receptor (TKR) family and is highly homologous to receptor PDGF and CSF-1. This antibody recognizes the extracellular domain and is expressed by a variety of normal and abnormal cell types. In abnormal cells, CD117 has been shown to label testicular germ cells, endometrial carcinomas, papillary and follicular thyroid carcinomas, small cell carcinomas, melanomas and ovarian epithelial carcinomas. It has also been shown to be an effective marker for mast cell disorders, gastrointestinal stromal tumors and immunotyping of blasts in human bone marrow.CD117/c-kit labels testicular germ cells, melanomas and endometrial, thyroid, small cell and ovarian epithelial carcinomas. It is an effective marker for mast cell disorders, gastrointestinal stromal tumors and human bone marrow blasts.
CD117/c-kit is a member of Tyrosine Kinase kDa (-3) Receptor (TKR) family and is highly homologous to receptor PDGF and CSF-1. This antibody recognizes the extracellular domain and is expressed by a variety of normal and abnormal cell types. In abnormal cells, CD117 has been shown to label testicular germ cells, endometrial carcinomas, papillary and follicular thyroid carcinomas, small cell carcinomas, melanomas and ovarian epithelial carcinomas. It has also been shown to be an effective marker for mast cell disorders, gastrointestinal stromal tumors and immunotyping of blasts in human bone marrow.CD117/c-kit labels testicular germ cells, melanomas and endometrial, thyroid, small cell and ovarian epithelial carcinomas. It is an effective marker for mast cell disorders, gastrointestinal stromal tumors and human bone marrow blasts.